Janet L Kwiatkowski

9PUBLICATIONS
22CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)NeonatologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Patient safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 24, 2026
Isovolemic hemodilution red cell exchange and blood use in children and young adults with sickle cell disease.

|Apr 01, 2026
Current therapeutic landscape of β-thalassemia: focus on gene therapy.

Aaron N Cheng, Janet L Kwiatkowski

|Mar 02, 2024
Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.

Janet L Kwiatkowski, Alexis A Thompson, Fernando Tricta

|Nov 30, 2021
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study.

Janet L Kwiatkowski, Mona Hamdy, Amal El-Beshlawy

|May 29, 2020
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.

Hanny Al-Samkari, Kathryn Addonizio, Bertil Glader

|Feb 12, 2020
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.

Paola Bianchi, Elisa Fermo, Kimberly Lezon-Geyda

Pageof 2

Frequent Collaborators

3 joint publications

Rachael F Grace

2 joint publications

Madeleine Verhovsek

2 joint publications

Kevin H M Kuo

2 joint publications

Julie Kanter